Home/Filings/4/0001078782-20-000242
4//SEC Filing

DAHL ANDREW A 4

Accession 0001078782-20-000242

CIK 0001101026other

Filed

Apr 7, 8:00 PM ET

Accepted

Apr 8, 4:04 PM ET

Size

7.5 KB

Accession

0001078782-20-000242

Insider Transaction Report

Form 4
Period: 2019-11-15
DAHL ANDREW A
President, CEO
Transactions
  • Award

    Common Stock Purchase Option

    2019-11-15+28,000,00028,000,000 total
    Exercise: $0.10From: 2019-11-15Exp: 2029-11-15Common Stock (28,000,000 underlying)
  • Award

    Common Stock Purchase Option

    2019-12-06+1,000,0001,000,000 total
    Exercise: $0.14From: 2019-12-06Exp: 2029-12-06Common Stock (1,000,000 underlying)
Footnotes (1)
  • [F1]The warrants were issued to the reporting person as compensation for his services as President and CEO.

Issuer

Zivo Bioscience, Inc.

CIK 0001101026

Entity typeother

Related Parties

1
  • filerCIK 0001537603

Filing Metadata

Form type
4
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:04 PM ET
Size
7.5 KB